Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)

Stopped Due to more robust long-term data generated in other active-controlled studies

Conditions

• Chronic Renal Failure
• Chronic Kidney Disease
• Anemia

Interventions

• DRUG: peginesatide
• DRUG: peginesatide

Sponsor

Affymax